| Literature DB >> 35630870 |
Gabriela Petrisor1,2,3, Denisa Ficai2,3,4, Ludmila Motelica1,2,3, Roxana Doina Trusca1,2,3, Alexandra Cătălina Bîrcă1,2,3, Bogdan Stefan Vasile1,2,3, Georgeta Voicu1,2,3, Ovidiu Cristian Oprea2,3,4, Augustin Semenescu5,6, Anton Ficai1,2,3,6, Mircea Ionut Popitiu7, Irina Fierascu8,9, Radu Claudiu Fierascu8,9, Elena Lacramioara Radu10, Lilia Matei10, Laura Denisa Dragu10, Ioana Madalina Pitica10, Mihaela Economescu10, Coralia Bleotu10.
Abstract
This paper aimed to develop two types of support materials with a mesoporous structure of mobile crystalline matter (known in the literature as MCM, namely MCM-41 and MCM-48) and to load them with gallic acid. Soft templating methodology was chosen for the preparation of the mesoporous structures-the cylindrical micelles with certain structural characteristics being formed due to the hydrophilic and hydrophobic intermolecular forces which occur between the molecules of the surfactants (cetyltrimethylammonium bromide-CTAB) when a minimal micellar ionic concentration is reached. These mesoporous supports were loaded with gallic acid using three different types of MCM-gallic acid ratios (1:0.41; 1:0.82 and 1:1.21)-and their characterizations by FTIR, SEM, XRD, BET and drug release were performed. It is worth mentioning that the loading was carried out using a vacuum-assisted methodology: the mesoporous materials are firstly kept under vacuum at ~0.1 barr for 30 min followed by the addition of the polyphenol solutions. The concentration of the solutions was adapted such that the final volume covered the wet mesoporous support and-in this case-upon reaching normal atmospheric pressure, the solution was pushed inside the pores, and thus the polyphenols were mainly loaded inside the pores. Based on the SBET data, it can be seen that the specific surface area decreased considerably with the increasing ratio of gallic acid; the specific surface area decreased 3.07 and 4.25 times for MCM-41 and MCM-48, respectively. The sample with the highest polyphenol content was further evaluated from a biological point of view, alone or in association with amoxicillin administration. As expected, the MCM-41 and MCM-48 were not protective against infections-but, due to the loading of the gallic acid, a potentiated inhibition was recorded for the tested gram-negative bacterial strains. Moreover, it is important to mention that these systems can be efficient solutions for the recovery of the gut microbiota after exposure to antibiotics, for instance.Entities:
Keywords: antimicrobial; drug delivery; dysbiosis; gallic acid; inflammasome; mesoporous materials; soft template
Year: 2022 PMID: 35630870 PMCID: PMC9147919 DOI: 10.3390/nano12101648
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Figure 1Structure of gallic acid.
Synthesized MCM/gallic acid mesoporous materials.
| Sample Code | Materials Type | Mass Ratio |
|---|---|---|
| MCM-41 | MCM-41 | |
| MCM-41_1 | MCM-41: Gallic acid | 1:0.41 |
| MCM-41_2 | MCM-41: Gallic acid | 1:0.82 |
| MCM-41_3 | MCM-41: Gallic acid | 1:1.21 |
| MCM-48 | MCM-48 | |
| MCM-48_1 | MCM-48: Gallic acid | 1:0.41 |
| MCM-48_2 | MCM-48: Gallic acid | 1:0.82 |
| MCM-48_3 | MCM-48: Gallic acid | 1:1.21 |
Working conditions used in the release of gallic acid from mesoporous silica.
| Sample Code | Total Mass Used | Mass of MCM-X | Mass of GA | Volume SGF/SIF |
|---|---|---|---|---|
| MCM-41_1 | 50 | 35.46 | 14.54 | 140 |
| MCM-41_2 | 50 | 27.47 | 22.53 | 140 |
| MCM-41_3 | 50 | 22.62 | 27.38 | 140 |
| MCM-48_1 | 50 | 35.46 | 14.54 | 140 |
| MCM-48_2 | 50 | 27.47 | 22.53 | 140 |
| MCM-48_3 | 50 | 22.62 | 27.38 | 140 |
Figure 2XRD diffractograms of samples: (a) MCM-41, MCM-41_1, MCM-41_2, MCM-41_3; (b) MCM-48, MCM-48_1, MCM-48_2, MCM-48_3.
Figure 3Absorption isotherms recorded on materials (a) MCM-41, MCM-41_1-3, and (c) MCM-48 and MCM-48_1-3 and pore size distribution histograms for (b) MCM-41 and (d) MCM-48.
BET characteristics of mesoporous materials.
| Sample Code | SBET | Vpors |
|---|---|---|
| MCM-41 | 1179.63 | 0.7634 |
| MCM-41_1 | 666.16 | 0.3421 |
| MCM-41_2 | 536.30 | 0.2800 |
| MCM-41_3 | 384.63 | 0.2039 |
| MCM-48 | 1482.00 | 0.7486 |
| MCM-48_1 | 585.85 | 0.3641 |
| MCM-48_2 | 458.98 | 0.2870 |
| MCM-48_3 | 348.147 | 0.1897 |
Figure 4FTIR spectra of samples (a) MCM-41, MCM-41_1–3, and (b) MCM-48 and MCM-48_1–3.
Figure 5SEM images of (a) MCM-41 mesoporous materials loaded with gallic acid and (b) MCM-48 mesoporous materials loaded with gallic acid.
Figure 6TEM images of the mesoporous supports (a) MCM-41 and (b) MCM-48 at lower and higher magnification.
Figure 7TG-DSC curves for the MCM41 and MCM41-GA samples.
MCM-41/MCM-48 characteristics from the TGA values.
| Sample | Mass Loss% | Mass Loss% | Endo | Residual Mass % (90 °C) | nH2O | nOH | NH2O | NOH |
|---|---|---|---|---|---|---|---|---|
| MCM-41 | 0.57 | 2.66 | 63.9 | 96.89 | 0.32 | 2.96 | 0.16 | 1.51 |
| MCM-48 | 0.36 | 2.77 | 64.7 | 96.86 | 0.20 | 3.08 | 0.08 | 1.25 |
Figure 8TG-DSC curves for the MCM48 and MCM48-GA samples.
Estimation of mesoporous material loading (using residual masses).
| Sample | Mass Loss (%) | Mass Loss (%) | Mass Loss (%) | Residual Mass (%) | GA Content (%) |
|---|---|---|---|---|---|
| MCM-41_1 | 8.56 | 4.93 | 25.49 | 60.52 | 37.54% |
| MCM-41_2 | 6.77 | 6.91 | 40.12 | 45.78 | 52.75% |
| MCM-41_3 | 5.75 | 7.41 | 48.40 | 38.12 | 60.66% |
| MCM-48_1 | 10.03 | 4.06 | 26.22 | 59.06 | 39.03% |
| MCM-48_2 | 7.83 | 6.46 | 39.73 | 45.46 | 53.07% |
| MCM-48_3 | 8.40 | 6.59 | 42.81 | 41.79 | 56.86% |
Figure 9Gallic Acid release from mesoporous support types (a) MCM-41 and (b) MCM-48 in SGF and SIF.
The CMI was established for AMX with and without the addition of prebiotics.
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|
| AMX | <3.9 | >1000 | >1000 | >1000 | >1000 | >1000 | >1000 | <2 | |
| Gallic acid | 150 µg/mL | <7.81 | >1000 | >1000 | >1000 | >1000 | >1000 | >1000 | <3.9 |
| 500 µg/mL | <7.81 | >1000 | >1000 | >1000 | >1000 | >1000 | >1000 | <2 | |
| MCM41-gallic acid | 150 µg/mL | <7.81 | >1000 | >1000 | >1000 | >1000 | >1000 | >1000 | <2 |
| 500 µg/mL | <1 | <1 | <1 | <1 | >1000 | <1 | <1 | <1 | |
| MCM48-gallic acid | 150 µg/mL | <1.95 | >1000 | >1000 | >1000 | >1000 | >1000 | >1000 | <2 |
| 500 µg/mL | <1 | <1 | <1 | <1 | >1000 | <1 | <1 | <1 |
Figure 10Characterization of prebiotic-induced toxic effects in HT29 cells using the CellTiter-Glo® Luminescent Cell Viability Assay.
Figure 11Inflammasome activation in cells infected with prebiotic-treated bacteria (HT29 cells). The signal-dependent activation is shown in red (prebiotic-GA) and blue (E. coli treated with prebiotic). Cell autofluorescence was eliminated by subtracting the RLU of the control cells from the RLU value of each experimental point.
Figure 12The mRNA expression level of the molecules involved in inflammation.
Figure 13The mRNA expression levels of the molecules involved in apoptosis.
Figure 14The mRNA expression levels of some cellular membrane molecules.